The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key markets has introduced considerable uncertainty . Investors are now assessing the impact of generic competition , red